Injectable peptides are the new anti-aging trend sweeping the beauty industry. These compounds are promoted on social media ...

GLP-1 users are posting about side effects and symptoms not seen in clinical trials, including irregular periods, fatigue, ...

By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated ...

Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a ...

Researchers analysed more than 400,000 social media posts in a bid to identify lesser-known issues linked to widely used GLP-1 medications semaglutide and tirzepatide.

A large 23andMe-based GWAS found that common variants in GLP1R and GIPR help explain why some people lose more weight or ...

With the rapid introduction of novel breast cancer therapies, recognizing and managing side effects is essential to maintain adherence and improve outcomes. As novel oral endocrine therapies and ...

Cardiac toxicities such as myocarditis are rare but carry a high risk of being fatal. The data emphasize that the most ...

The Food and Drug Administration issued a warning letter to Novo Nordisk — the maker of Ozempic and Wegovy — for failing to report potential side effects in patients who took its blockbuster ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

Novo Nordisk NOVO.B-0.87%decrease; red down pointing triangle received a warning from the Food and Drug Administration for failing to report serious suspected side effects in patients who took the ...